BDX Stock Analysis: Buy, Sell, or Hold?
BDX - Becton, Dickinson and Co.
$156.34
-0.89 (-0.57%)
▼
5d:
-1.22%
30d:
-10.26%
90d:
-20.09%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation
BDX is down 3.5% this week, but smart money is accumulating calls. Top strike: $170 2026-05-15 with 468 OI. Call ratio: 88% View Scanner →
Strength: 5.6/10
Get Alerted When BDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BDX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: BDX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$232.26
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$144.21
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BDX is currently trading at $156.34, which is considered slightly low relative to its 30-day fair value range of $155.41 to $174.09. The stock's valuation (Forward PE: 11.6) is in line with its historical norms (12.7). Remarkably, the market is currently pricing in an annual earnings decline of 3.1% over the next few years. This pessimistic expectation contrasts with the company's recent 28.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BDX is in a strong uptrend. The price is currently testing key support at $153.18. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $196.08 (+25.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BDX is in a strong uptrend. The price is currently testing key support at $153.18. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $196.08 (+25.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$155.41 -
$174.09
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.4% below Wall St target ($196.08)
Fair Price Analysis
30-Day Fair Range
$155.41 -
$174.09
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$153.18
Resistance Level
$160.19
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.57
Wall Street Target
$196.08
(+25.4%)
Revenue Growth (YoY)
1.6%
Earnings Growth (YoY)
28.6%
Profit Margin
8.0%
Valuation Discount vs History
-3.1% cheaper
PE vs Historical
11.6 vs 12.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.1%
(market-implied from PE analysis)
1-Year Target
$151.49
(-3%)
2-Year Target
$146.80
(-6%)
3-Year Target
$142.25
(-9%)
3-Yr Target (if PE normalizes)
(PE: 12→13)
$156.15
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 8.5%)
$385.51
(+147%)
Base:
(SPY PE: 11.6, Growth: 8.5%)
$199.55
(+28%)
Bear:
(PE: 9.8, Growth: 8.5%)
$169.62
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 25.18 | Current EPS (TTM): $6.12
Bull Case
$339.09
(+117%)
Analyst growth 100.0%, PE expands to 27.7
Base Case
$308.26
(+97%)
Market implied 100.0%, PE stable at 25.2
Bear Case
$104.81
(-33%)
Severe decline -20.0%, PE contracts to 21.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.6 to 12.7
Stabilization Target:
$171.62
(+9.8%)
PE Expansion Potential:
+9.8%
Share & Embed Analysis
Last updated: April 02, 2026 5:45 AM ET
Data refreshes hourly during market hours. Next update: 6:45 AM
Data refreshes hourly during market hours. Next update: 6:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Feld
SELL
75 shares
2026-02-26
Bertram L Scott
SELL
953 shares
2026-02-18
Ro Khanna
BUY
2026-01-29
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 61 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 59 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$297 | 61 BUY |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 62 BUY |
Advanced BDX Option Strategies
Professional options setups generated by AI based on today's BDX price and gamma walls.
